Plasma Fractionation Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Plasma Fractionation Market 

5.1. COVID-19 Landscape: Plasma Fractionation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Plasma Fractionation Market, By Product

8.1. Plasma Fractionation Market, by Product, 2024-2033

8.1.1. Albumin

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Immunoglobulins

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Coagulation Factors

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Protease Inhibitors

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Plasma Fractionation Market, By Method

9.1. Plasma Fractionation Market, by Method, 2024-2033

9.1.1. Centrifugation

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Depth Filtration

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Chromatography

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Plasma Fractionation Market, By Application 

10.1. Plasma Fractionation Market, by Application, 2024-2033

10.1.1. Neurology

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Hematology

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Oncology

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Immunology

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Pulmonology

10.1.5.1. Market Revenue and Forecast (2021-2033)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Plasma Fractionation Market, By End-use 

11.1. Plasma Fractionation Market, by End-use, 2024-2033

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Clinical Research

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Plasma Fractionation Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Forecast, by Method (2021-2033)

12.1.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Forecast, by End-use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Method (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Method (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Forecast, by Method (2021-2033)

12.2.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Method (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Method (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Method (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Method (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Forecast, by Method (2021-2033)

12.3.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Method (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Method (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Method (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Method (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Forecast, by Method (2021-2033)

12.4.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Method (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Method (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Method (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Method (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Forecast, by Method (2021-2033)

12.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Method (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Method (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 13. Company Profiles

13.1. Grifols S.A.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. CSL Limited

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Takeda Pharmaceutical Company Limited

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Octapharma AG

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Kedrion S.p.A

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. LFB S.A.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Biotest AG

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Sanquin

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Bio Products Laboratory Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Intas Pharmaceuticals Ltd

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms